Research article · 25 Jun 2026
OpinionPublished 25 Mar 2022
General Therapeutics for HIV
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
As a result of the HIV epidemic's acceleration, is now the leading cause of mortality for HIV-positive people worldwide, accounting for 22% (350,000) of all HIV-related fatalities worldwide. Of the 8.8 million incident cases of HIV reported worldwide in 2010, 1.1 million affected HIV-positive individuals . There is now convincing evidence that treating HIV patients concurrently, as opposed to starting Antiretroviral (ARV) medications after HIV treatment is finished, lowers mortality. Because of this, cotreatment has become the norm for the majority of patients. Although 6 months of combination therapy are still necessary for the treatment of drug-sensitive HIV, there are methods being researched and must be evaluated among patients.
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in HIV: Current Research.
Perspective · 25 Apr 2025
Digital Age HIV Stigma and the Role of Online Communities
Short communication · 1 Apr 2025
Mental Health Inclusion in HIV Management toward Whole-Person Care
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalHIV: Current Research
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Mohammed amin akbar khan”

